Insiders · FDMT

David Schaffer

Director at 4D Molecular Therapeutics Inc. (FDMT)

David Schaffer has filed 4 insider reports with the SEC since May 2021, as director at 4D Molecular Therapeutics Inc. (FDMT). David Schaffer made no open-market purchases or sales in the last 12 months. In the latest filing, on October 23, 2021, David Schaffer sold 36,285 shares of 4D Molecular Therapeutics Inc. (FDMT) for $1.14M at an average of $31.36.

Filings
4
Companies
1
Bought on market
None
Sold on market
$3.01M

Companies where David Schaffer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
4D Molecular Therapeutics Inc. logo
FDMT
4D Molecular Therapeutics Inc.
Director901,215$3.01M$10.46Oct 23, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Schaffer with

Other insiders at the same companies

Questions about David Schaffer

What is David Schaffer's role at 4D Molecular Therapeutics Inc.?
David Schaffer reports to the SEC as director at 4D Molecular Therapeutics Inc. (FDMT), according to the latest filing on October 23, 2021.
How many shares does David Schaffer own?
After the latest filing that states it, David Schaffer directly owned 901,215 shares of 4D Molecular Therapeutics Inc. (FDMT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Schaffer bought or sold stock recently?
The most recent open-market sale was on October 22, 2021: sold 36,285 shares of 4D Molecular Therapeutics Inc. (FDMT) for $1.14M at an average of $31.36.
How do I get alerts when David Schaffer files?
Follow David Schaffer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Schaffer (SEC CIK 0001692929). Totals count each trade once, skipping amendments whose original is on file, from May 20, 2021 on. View on SEC EDGAR